Topic

Blue Cross Blue Shield (BCBS Association)

A collection of 1266 issues

How to Get Jynarque (Tolvaptan) Covered by Blue Cross Blue Shield in California: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Jynarque Covered in California Blue Shield of California requires prior authorization for Jynarque (tolvaptan) for ADPKD patients 18+ prescribed by nephrologists. Submit via AuthAccel portal or fax (800) 633-4581 with baseline eGFR, imaging showing rapid progression, and REMS enrollment. Standard review takes 14 business days. If denied,
5 min read

How Long Does It Take to Get Synagis (Palivizumab) Approved by Blue Cross Blue Shield in Virginia? Complete Timeline Guide

Answer Box: Synagis Approval Timeline in Virginia Blue Cross Blue Shield Virginia (Anthem) requires prior authorization for Synagis (palivizumab), typically taking 5-14 days for standard reviews. High-risk infants (≤35 weeks gestation, chronic lung disease, congenital heart disease) have the best approval odds when complete clinical documentation is submitted upfront. Start
4 min read

How to Get Garadacimab (Andembry) Covered by Blue Cross Blue Shield in Washington: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Garadacimab Covered by BCBS in Washington Garadacimab (Andembry) requires prior authorization from Blue Cross Blue Shield plans in Washington. Submit a formulary exception request with confirmed HAE diagnosis (ICD-10 D84.1), lab results showing low C4 and C1-INH levels, and documentation of prior therapy failures. If denied,
6 min read

How to Get Taltz (Ixekizumab) Covered by Blue Cross Blue Shield in Pennsylvania: Prior Authorization Guide & Appeal Scripts

Quick Answer: Getting Taltz Covered in Pennsylvania Blue Cross Blue Shield plans in Pennsylvania require prior authorization for Taltz (ixekizumab), typically including step therapy with at least one TNF inhibitor failure. Most commercial and health exchange plans classify Taltz as non-preferred, while Medicaid managed plans may offer preferred status. The
6 min read